Takeda Pharmaceuticals, Koneksa Health to introduce biosensors, wearable technology into clinical studies: 3 notes

Osaka, Japan-based Takeda Pharmaceuticals and New York City-based technology company Koneksa Health have partnered to integrate digital health tools into early-stage clinical trials.

Here's what you need to know:

1. Takeda Pharmaceuticals will introduce biosensors and wearable technology into a select group of clinical studies, using Koneksa Health's technology data platform.

2. The Koneksa Health platform will allow researchers to remotely collect patient data, such as vital signs, activity levels and sleep metrics.

3. Ongoing remote data collection will help Takeda Pharmaceuticals study disease progression, treatment effects and safety profiles of its new drugs, which focus on treating oncology, gastroenterology and central nervous system conditions.

More articles on gastroenterology and endoscopy:
Women's cancer deaths to increase by 60% through 2030: 5 colorectal cancer findings
Aspirin reduces risk of tumors with low levels of tumor-infiltrating lymphocytes: 3 study insights
Inflammatory bowel disease 3 times more common than previous estimates: 5 takeaways

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers